CSIMarket
 
Standard Biotools Inc   (NASDAQ: LAB)

Select the Financial Report: Select the Period:


Description of Standard Biotools Inc's Business Segments


Standard Biotools Inc. is a biotechnology company that specializes in the development and delivery of innovative tools and solutions for life sciences research and clinical applications. The company offers a diverse range of products and services tailored for various segments within the biotechnology, pharmaceutical, and academic research industries. Below is an extensive overview of the segments, products, and services provided by Standard Biotools Inc.

Segments

1. Research and Development:
- Focused on providing tools and technologies that enable researchers to enhance their workflows, from basic research to applied science.
- Products in this segment cater to molecular biology, genomics, proteomics, and other related fields.

2. Clinical applications:
- Provides diagnostic tools and services aimed at healthcare professionals and research institutions.
- Enables precise and accurate solutions for patient care, laboratory testing, and diagnostics.

3. Pharmaceutical Development:
- Supports drug discovery and development processes with specialized tools and technologies.
- Offers solutions for bioanalytical testing, quality control, and process development.

4. Industrial Biotechnology:
- Supplies instruments and reagents used in biomanufacturing and process optimization.
- Targets industries looking to enhance productivity and efficiency in biological product development.

Products

1. Instruments:
- Flow Cytometers: High-performance systems for cell analysis, used in immunology, oncology, and stem cell research. These instruments are equipped with advanced detection technologies to provide high-resolution data on cellular populations.
- Mass Spectrometers: Used for analyzing biomolecules, offering high sensitivity and specificity for applications in proteomics, metabolomics, and drug analysis.
- Microarray Platforms: Tools for high-throughput analysis of gene expression and genotyping, facilitating studies in genomics and personalized medicine.

2. Reagents and Kits:
- PCR and qPCR Reagents: Comprehensive solutions for polymerase chain reaction including enzymes, primers, and buffers, designed for high specificity and yield in DNA amplification studies.
- Protein Assay Kits: Reagents for quantifying protein concentration, including colorimetric, fluorometric, and bioluminescent assays that cater to various experimental needs.
- Cell Culture Media: Formulations optimized for the growth and maintenance of a wide variety of cell types, including primary cells, immortalized cell lines, and stem cells.

3. Consumables:
- Lab Plastics: Wide range of consumables including pipette tips, microcentrifuge tubes, and plates, essential for daily laboratory operations.
- Cell Culture Vessels: High-quality flasks, dishes, and plates designed for optimal cell growth and experimentation.

4. Bioinformatics Software:
- Tools that assist researchers in data analysis, visualization, and interpretation, aimed at integrating with experimental workflows in genomics and proteomics.
- Supports the interpretation of complex data, allowing for better decision-making in research and clinical applications.

Services

1. Technical Support and Training:
- Expert assistance in utilizing products effectively to maximize researchers abilities to achieve their experimental goals.
- Training sessions and workshops to educate users on best practices and latest advancements in biotechnological applications.

2. Custom Solutions Development:
- Collaboration with clients to develop tailored products or protocols that meet specific research needs.
- Focuses on providing bespoke services that enhance experimental outcomes and operational efficiency.

3. Contract Research Services:
- Offers outsourced research services including analytical testing, assay development, and bioconjugation of biomolecules to support both academic and commercial projects.
- Provides expertise and resources to expedite research timelines and improve productivity.

4. Regulatory Compliance Assistance:
- Provides guidance in navigating the regulatory landscape for product development and implementation, particularly in clinical applications and pharmaceutical sectors.
- Ensures that end products and services comply with relevant standards and regulations, facilitating smoother routes to market.

In summary, Standard Biotools Inc. is committed to advancing the life sciences through its wide-ranging portfolio of high-quality products and services designed for research, diagnostics, and pharmaceutical applications. Its focus on innovation, quality, and client support positions it as a key player in the biotechnology sector.


Composition of Standard Biotools Inc Revenues by Segments

 
Instruments    26.15 % of total Revenue
Consumables    44.68 % of total Revenue
Product revenue    70.83 % of total Revenue
Services and other revenue    29.52 % of total Revenue
Americas    40.25 % of total Revenue
EMEA    37.18 % of total Revenue
Asia-Pacific    22.92 % of total Revenue

Q3 three months ended (Sep 30 2025)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Instruments 5.10 26.15 %
Consumables 8.71 44.68 %
Product revenue 13.80 70.83 %
Services and other revenue 5.75 29.52 %
Americas 7.84 40.25 %
EMEA 7.25 37.18 %
Asia-Pacific 4.47 22.92 %
Total 19.48 100 %




Q3 three months ended (Sep 30 2025)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Instruments -3.34 % -2.3 %
Consumables -17.16 % -16.76 %
Product revenue -12.54 % -11.95 %
Services and other revenue -8.8 % -5.53 %
Americas -19.65 % -9.75 %
EMEA -18.39 % -20.63 %
Asia-Pacific 29.5 % 13.18 %
Total -55.98 % -9.91 %




Q3 three months ended (Sep 30 2025)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -34.69 -




Q3 three months ended (Sep 30 2025)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on Standard Biotools Inc Divisions, Sales by Country

 
Instruments   Instruments Segment contribution to total sales 16.36 % of total Revenue
Consumables   Consumables Segment contribution to total sales 34.47 % of total Revenue
Product revenue   Product revenue Segment contribution to total sales 50.82 % of total Revenue
Americas   Americas Segment contribution to total sales 53.63 % of total Revenue
EMEA   EMEA Segment contribution to total sales 30.02 % of total Revenue
Asia-Pacific   Asia-Pacific Segment contribution to total sales 16.44 % of total Revenue
Assay services   Assay services Segment contribution to total sales 32.41 % of total Revenue
Instrument support services   Instrument support services Segment contribution to total sales 14.14 % of total Revenue
Service revenue   Service revenue Segment contribution to total sales 46.56 % of total Revenue
Product and service revenue   Product and service revenue Segment contribution to total sales 97.38 % of total Revenue
Collaboration and other revenue   Collaboration and other revenue Segment contribution to total sales 2.71 % of total Revenue
NEC   NEC Segment contribution to total sales 0.29 % of total Revenue
Illumina   Illumina Segment contribution to total sales -0.23 % of total Revenue
Other   Other Segment contribution to total sales 5.82 % of total Revenue
Proteomics segments   Proteomics segments Segment contribution to total sales 77.92 % of total Revenue
Genomics segments   Genomics segments Segment contribution to total sales 22.18 % of total Revenue


Twelve months ended 2024
LAB s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Instruments 28.50 16.36 %
Consumables 60.06 34.47 %
Product revenue 88.57 50.82 %
Americas 93.46 53.63 %
EMEA 52.32 30.02 %
Asia-Pacific 28.65 16.44 %
Total 174.26 100 %
Assay services 56.48 32.41 %
Instrument support services 24.65 14.14 %
Service revenue 81.13 46.56 %
Product and service revenue 169.70 97.38 %
Collaboration and other revenue 4.73 2.71 %
NEC 0.50 0.29 %
Illumina -0.41 -0.23 %
Other 10.14 5.82 %
Proteomics segments 135.79 77.92 %
Genomics segments 38.64 22.18 %


Twelve months ended 2024
LAB s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -138.89 -

Twelve months ended 2024
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Instruments -23.91 % -
Consumables 43.9 % -
Product revenue 11.83 % -
Americas 102.32 % -
EMEA 44.52 % -
Asia-Pacific 19.66 % -
Total 65.26 % -
Assay services 7900.57 % -
Instrument support services -2.47 % -
Service revenue 212.29 % -
Product and service revenue 61.35 % -
Collaboration and other revenue 307.14 % -
Other -8.52 % -
Proteomics - -
Genomics - -
Proteomics segments 112.56 % -
Genomics segments -8.98 % -
Total product and service revenue - -
Total other revenue - -



Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.